Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page
- ChecktodayChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, reflecting a software update to the ClinicalTrials.gov page. This change does not alter the study details, eligibility criteria, or results presented on the page.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating an update to the page's revision metadata.SummaryDifference0.0%

- Check21 days agoChange DetectedA line noting '2019 ( U.S. NIH Grant/Contract )' was added to the study's funding/identifiers section. This indicates NIH support for the study in 2019.SummaryDifference0.0%

- Check35 days agoChange DetectedThe page's revision number updated from v3.6.4 to v3.6.5, indicating a minor site update that does not alter study details or content. No user-facing data or navigation is affected.SummaryDifference0.0%

- Check42 days agoChange DetectedRemoved the Plain Language Results Summary, sponsor attribution (Sanofi), and the Helpful Links section. This alters the page’s accessibility and navigational context by removing high-level explanations and branding cues.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, reflecting a new build of the site template. This deployment note helps track changes to the page rendering without altering the study content.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.